The emergence of Vancomycin resistant enterococci (VRE) has posed serious threats to the community because they exhibit multiple drug
resistance, thus limiting the therapeutic options for the clinicians. As Vancomycin resistant enterococci (VRE) also have ampicillin resistance and
high level aminoglycoside resistance, they are the most difcult to treat. The therapeutic options are limited by elimination of the synergy between
aminoglycoside and the beta lactum drugs which is the treatment of choice for enterococcal infections which is of great concern. More antibiotic
resistance makes these pathogens excellent survivors in hospital environment and cause nosocomial infections. Atotal of 142 enterococcal isolates
from various clinical samples were identied to their species level and subjected to antimicrobial susceptibility testing to various antibiotics. Initial
screening for Vancomycin resistance was done using the Vancomycin Screen Agar and the isolates showing resistance were subjected to
Vancomycin and Teicoplanin MIC and later these isolates showing resistance were conrmed by genotypic methods for Vancomycin resistant
genes.Total VRE isolates as per Vancomycin MIC value were 19 and the prevalence rate was 13.3% (19/142).In PCR assay, a total of 16 isolates
including 13 E.faecium and 3 E.faecalis were found to be of Van B genotype and the remaining 3 isolates including 2 E.faecium and 1 E.faecalis
were found to be of Van A genotype. In this study, the prevalence of Vancomycin resistance in Enterococcal species is 13.3% as per vancomycin
MIC by Micro broth dilution technique. The phenotypic detection of Vancomycin resistance by MIC of Vancomycin and Teicoplanin correlates
with the genotypic method of detection of Vancomycin resistant genes (VanA, VanB).